Ovintiv (OVV) – Investment Analysts’ Recent Ratings Updates
Ovintiv (NYSE: OVV) has recently received a number of price target changes and ratings updates: 12/1/2025 – Ovintiv had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/26/2025 – Ovintiv is now covered by analysts at William Blair. They set an “outperform” rating and a $50.00 price target on the stock. 11/26/2025 – […]
Centuri (CTRI) – Investment Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Centuri (NYSE: CTRI) in the last few weeks: 12/1/2025 – Centuri had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings. 11/24/2025 – Centuri had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings. 11/17/2025 – Centuri had its “sell (d+)” […]
DuPont de Nemours (DD) – Research Analysts’ Recent Ratings Updates
A number of firms have modified their ratings and price targets on shares of DuPont de Nemours (NYSE: DD) recently: 12/1/2025 – DuPont de Nemours had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings. 11/25/2025 – DuPont de Nemours had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings. 11/25/2025 – DuPont […]
Recent Research Analysts’ Ratings Updates for Olema Pharmaceuticals (OLMA)
Olema Pharmaceuticals (NASDAQ: OLMA) recently received a number of ratings updates from brokerages and research firms: 11/21/2025 – Olema Pharmaceuticals had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $26.00. They now have a “buy” rating on the stock. 11/18/2025 – Olema Pharmaceuticals had its price target raised […]
Analysts’ Recent Ratings Updates for Faraday Future Intelligent Electric (FFAI)
A number of research firms have changed their ratings and price targets for Faraday Future Intelligent Electric (NASDAQ: FFAI): 12/1/2025 – Faraday Future Intelligent Electric had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings. 11/24/2025 – Faraday Future Intelligent Electric had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings. 11/20/2025 – […]
Kinross Gold (KGC) – Investment Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Kinross Gold (NYSE: KGC) in the last few weeks: 12/1/2025 – Kinross Gold had its price target raised by analysts at UBS Group AG from $31.00 to $33.00. They now have a “buy” rating on the stock. 11/30/2025 – Kinross Gold was downgraded […]
Omega Healthcare Investors (OHI) – Research Analysts’ Recent Ratings Updates
Omega Healthcare Investors (NYSE: OHI) has recently received a number of price target changes and ratings updates: 12/1/2025 – Omega Healthcare Investors had its price target raised by analysts at Truist Financial Corporation from $44.00 to $46.00. They now have a “hold” rating on the stock. 11/25/2025 – Omega Healthcare Investors had its price target […]
Eli Lilly and Company (LLY) – Research Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for Eli Lilly and Company (NYSE: LLY): 12/2/2025 – Eli Lilly and Company had its “outperform” rating reaffirmed by analysts at BMO Capital Markets. They now have a $1,100.00 price target on the stock. 12/2/2025 – Eli Lilly and Company had its price […]
Research Analysts’ Recent Ratings Updates for Brinker International (EAT)
A number of firms have modified their ratings and price targets on shares of Brinker International (NYSE: EAT) recently: 12/1/2025 – Brinker International had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings. 11/28/2025 – Brinker International was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating. 11/25/2025 […]
Analysts’ Recent Ratings Updates for Alkermes (ALKS)
Alkermes (NASDAQ: ALKS) has recently received a number of price target changes and ratings updates: 11/20/2025 – Alkermes was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating. 11/17/2025 – Alkermes had its price target raised by analysts at Truist Financial Corporation from $50.00 to $55.00. They now have a […]
Research Analysts’ Recent Ratings Updates for JPMorgan Chase & Co. (JPM)
JPMorgan Chase & Co. (NYSE: JPM) has recently received a number of price target changes and ratings updates: 11/25/2025 – JPMorgan Chase & Co. had its “buy (b+)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – JPMorgan Chase & Co. had its “buy (b+)” rating reaffirmed by analysts at Weiss Ratings. 11/18/2025 – JPMorgan […]
Investment Analysts’ Recent Ratings Updates for APA (APA)
A number of research firms have changed their ratings and price targets for APA (NASDAQ: APA): 11/26/2025 – APA had its price target raised by analysts at Citigroup Inc. from $24.00 to $25.00. They now have a “neutral” rating on the stock. 11/26/2025 – APA is now covered by analysts at William Blair. They set […]
Research Analysts’ Recent Ratings Updates for The Glimpse Group (VRAR)
The Glimpse Group (NASDAQ: VRAR) has recently received a number of price target changes and ratings updates: 11/24/2025 – The Glimpse Group had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings. 11/22/2025 – The Glimpse Group was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating. 11/17/2025 […]
Equitable (EQH) – Research Analysts’ Recent Ratings Updates
Equitable (NYSE: EQH) has recently received a number of price target changes and ratings updates: 11/24/2025 – Equitable had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/17/2025 – Equitable had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/16/2025 – Equitable was downgraded by analysts at Wall Street Zen from […]
Supernus Pharmaceuticals (SUPN) – Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for Supernus Pharmaceuticals (NASDAQ: SUPN): 11/25/2025 – Supernus Pharmaceuticals had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – Supernus Pharmaceuticals had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings. 11/13/2025 – Supernus Pharmaceuticals was downgraded by analysts […]
Papa John’s International (PZZA) – Investment Analysts’ Recent Ratings Updates
Papa John’s International (NASDAQ: PZZA) has recently received a number of price target changes and ratings updates: 11/24/2025 – Papa John’s International had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/17/2025 – Papa John’s International had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/10/2025 – Papa John’s International had […]
Apollo Commercial Real Estate Finance (ARI) – Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Apollo Commercial Real Estate Finance (NYSE: ARI) in the last few weeks: 11/25/2025 – Apollo Commercial Real Estate Finance had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 11/22/2025 – Apollo Commercial Real Estate Finance was downgraded by analysts at Wall […]
last updated on 5 Dec 00:55